Correction: Kumar et al. Harnessing Potential of ω-3 Polyunsaturated Fatty Acid with Nanotechnology for Enhanced Breast Cancer Therapy: A Comprehensive Investigation into ALA-Based Liposomal PTX Delivery. Pharmaceutics 2024, 16, 913.

Kumar R, Kumar A, Kumar D, Yadav S, Shrivastava NK, Singh J, Sonkar AB, Verma P, Arya DK, Kaithwas G, Agrawal AK, Singh S

Open source

DOI
10.3390/pharmaceutics18040479
Published
2026 Apr 14
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics18040479,
  title = {Correction: Kumar et al. Harnessing Potential of ω-3 Polyunsaturated Fatty Acid with Nanotechnology for Enhanced Breast Cancer Therapy: A Comprehensive Investigation into ALA-Based Liposomal PTX Delivery. Pharmaceutics 2024, 16, 913.},
  author = {Kumar R and Kumar A and Kumar D and Yadav S and Shrivastava NK and Singh J and Sonkar AB and Verma P and Arya DK and Kaithwas G and Agrawal AK and Singh S},
  year = {2026},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics18040479},
  url = {https://doi.org/10.3390/pharmaceutics18040479}
}

RIS

TY  - JOUR
TI  - Correction: Kumar et al. Harnessing Potential of ω-3 Polyunsaturated Fatty Acid with Nanotechnology for Enhanced Breast Cancer Therapy: A Comprehensive Investigation into ALA-Based Liposomal PTX Delivery. Pharmaceutics 2024, 16, 913.
AU  - Kumar R
AU  - Kumar A
AU  - Kumar D
AU  - Yadav S
AU  - Shrivastava NK
AU  - Singh J
AU  - Sonkar AB
AU  - Verma P
AU  - Arya DK
AU  - Kaithwas G
AU  - Agrawal AK
AU  - Singh S
PY  - 2026
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics18040479
UR  - https://doi.org/10.3390/pharmaceutics18040479
ER  - 

APA

R, K., A, K., D, K., S, Y., NK, S., J, S., AB, S., P, V., DK, A., G, K., AK, A., & S, S. (2026). Correction: Kumar et al. Harnessing Potential of ω-3 Polyunsaturated Fatty Acid with Nanotechnology for Enhanced Breast Cancer Therapy: A Comprehensive Investigation into ALA-Based Liposomal PTX Delivery. Pharmaceutics 2024, 16, 913.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18040479

Source records